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Abstract 
Pyrethroids are pesticides very used in agriculture, which tend to replace 
organophosfate and carbamate insecticides. These pesticides have shown to exhibit 
cardiotoxicity.                                                                                                                     
The aim of this study was to assess if cardiotoxicity is due to direct or indirect effects 
(metabolites) of permethrin on hearts. There were studies 8 rats; three  of them were 
sacrificed after 24 of the end of treatment with permethrin and the other  four were 
sacrificed after 14 days of the end of treatment. Afterwards hearts and urines were 
collected. The amounts of permethrin and its main metabolite (3-PBA) were 
evaluated on hearts and urines of female rats which were treated with permethrin and 
sacrificed the day after and 14 days after the treatment. Moreover has been 
highlighted the difference of amount of permethrin and its metabolite between rats 
sacrificed immediately at the end of treatment and those sacrificed after 14 days. The 
study of permethrin was accomplished by liquid-liquid extraction and GC-ECD. The 
evaluation of 3-PBA was performed by SPE procedure with 2-PBA as internal 
standard and gas-chromatography GC-MS.  The concentration of permethrin in hearts 
is basically the same in 24h and 14 days. The 3-PBA concentration in urines 
decreased 50 times from 24h to 14 days. In hearts the 3-PBA level also decrease but 
only 2.24 times and a high variation of results were achieved in rats after 14 days. 
Key-words: Pesticides, permethrin, metabolites, 3-phenoxybenzoic acid, 2-
phenoxybenzoic acid, chromatography, GC-MS, GC-ECD, extraction, derivatization, 
heart, urine  
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1.  Pesticide pyrethroid permethrin 
Permethrin, also called 3-phenoxybenzyl (1RS, 3RS, 1RS, 3SR)-3-(2,2-
dichlorovinyl)-2,2-dimethyl-cyclopropanecar-boxylate (IUPAC name), (1) (Fig.1) 
was the first synthetic pyrethroid photo-stable enough to be used in agriculture and 
the most used pyrethroid in USA. Synthetic pyrethroids derive from naturally 
occurring pyrethrins, which result from extracts of dried chrysanthemum flowers, and 
they are more stable and more toxic than natural pyrethroids. The most common uses 
of Permethrin are as an insecticide and a the treatment of ectoparasites (fleas, lice, 
scabie) on humans and animals, in residential sites and on clothing. Formulations of 
permethrin are considered pharmaceuticals and they are regulated by the United 
States Food and Drug Administration (FDA) (2); for example sprays, dusts, fogs, 
emulsifiable concentrates and creams can be found. Permethrin has a molecular 
weight of 391.3 g/mol , a solubility of 5.5 x 10-3 mg/L, 6x 10-3 mg/L and four 
isomers: (1S,trans)(1S,cis) (1R,trans) (1R,cis).The trans-isomer has a lower toxicity 
in rats than the corresponding cis-isomers and a more rapid degradation. 
 
 
 
Fig. 1 Chemical structure of permethrin 
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2. Toxicity and health effects 
According to their chemical structure Pyrethroids can cause: 
- T-syndrome (tremors, sensitivity to sensory stimuli, ataxia, convulsions and 
paralysis) 
-CS-syndrome (3) (choreoathetosis, hypersensitivity to external stimuli, salivation 
and, in some cases, paralysis) (4).                                                                  
Usually T-syndrome is caused by pyrethroids not containing an alpha-cyano group in 
their molecule and CS-syndrome derives by pirethroids with an alpha-cyano group. 
Many pyrethroids, such as permethrin, exhibit both T and CS characteristics and 
sometimes these two syndromes combine (6). Permethrin interferes with sodium 
channels to disrupt the function of neurons, and causes muscler to spasm, culminating 
in paralysis and death (1,2). Mammals can metabolize in a good way pyrethroids, 
such as permethrin, before they can affect the nervous system (5). The lethal dose 
(LD50) for permethrin is variable, ranging from 430 mg/kg body weight to over 4000 
mg/kg for rats (7). 
Permethrin can induce several toxic effects:                                                    
- Neurotoxicity: At high doses tremors, loss of coordination, hyperactivity, increase 
of body temperature can appear (7). Moreover motor deficits, learning and memory 
dysfunction can be the result of neuronal cell death caused by Permethrin. 
- Immune system toxicity: Even small doses of permethrin can reduce the ability of 
immune system to respond to foreign proteins. Over 40% of T-lymphocytes and 
natural killer (NK) cells are inhibited by a dose of Permethrin equivalent to 1/100 of 
the LD50 (8). 
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-Reproductive systems effects: Permethrin binds to receptors for androgen (9) and to 
the peripheral benzodiazepine receptor receptor (which stimulates production of 
testosterone) (10). Moreover it inhibits the binding of estradiol to the estrogen 
receptor (11). 
-Mutagenic effects: an increase in chromosome aberrations, chromosome fragments 
and DNA lesions (8) may occur after a permethrin exposure. 
-Cancer: According to the World Health Organization permethrin increased the 
frequency of lung tumors in female mice, increasing the expression of a gene 
involved with the proliferation of cells in mammary gland (12,13). The risk of 
prostate cancer in men with a family history of prostate cancer can increase because 
of Permethrin exposure (14). 
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2.1Toxicokinetics 
 
2.1.1 Absorption 
Permethrin is absorbed from the gastrointestinal tract, minimally through intact skin 
and by inhalation of dust and spray mist. Human case studies involving skin 
applications of permethrin indicated that about 0.5% of the applied dose was 
absorbed dermally (15). Animal studies showed that there is a quick and substantial 
absorption of permethrin upon ingestion (16). In one study of rats, about 60% of the 
orally administered dose was absorbed with an absorption half-life of less than one 
hour (17). No information was found regarding absorption rates following inhalation 
of permethrin. 
2.1.2 Distribution 
Feeding studies using rats indicated that permethrin was rapidly distributed 
throughout the body. Peak concentrations measured in plasma, nerve tissue, liver, and 
kidneys occurred around four hours after ingestion. Levels found in nervous tissues 
were generally higher compared with in plasma (17,18). A human case study 
involving an intentional ingestion of permethrin showed a similar distribution pattern 
with a peak permethrin concentration found in blood three to four hours after 
ingestion (19). 
2.1.3Metabolism 
In animal feeding studies using rats, goats, cows and hens, permethrin was 
metabolized quickly in the liver. Hydrolysis, hydroxylation, oxidation, and 
conjugation are all involved in the process of metabolism (16,20). While several 
metabolites of permethrin have been identified, permethrin itself is considered the 
only compound of toxicological significance (16,2). Permethrin is easily hydrolyzed, 
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and the hydrolysis product is also easily oxidised in rats in vitro. Permethrin is 
converted to PBAlc (3-Phenoxybenzyl alcohol) and further to PBAld and PBAcid by 
mixed function oxidase in rats (Fig.2). Trans-isomers are more rapidly metabolized 
by hydrolytic (esterase) pathways while cis-isomers are preferentially metabolized by 
slower oxidative (P450) pathways (21). The trans-isomer of permethrin is mainly 
catalyzed by the CES1 family and partly by the CES2 family. CES is a serine 
hydrolase and hydrolases substrates via a ping pong bi-bi mechanism, in which a 
tetrahedral intermediate is important (22). ES-3 and ES-10, isozymes of CES1 
exhibited significant hydrolase activities. The cis-isomer of permethrin, which is 
metabolized predominantly by P450’s in laboratory animals (21), was not detectably 
metabolized in human liver microsomes in the presence or absence of an NADPH 
regenerating system (23). Oxidations of PBAlc and PBAld are mainly mediated by 
mixed function oxidase, in addition to ADH (alcohol dehydrogenase) and ALDH 
(Aldhehyde dehydrogenase), which were shown to contribute to the oxidation by 
Hodson and coworkers (2002; 2003). The alcohol generated from permethrin, PBAlc 
is oxidized to PBAld (3-phenoxybenzylaldehyde), and the aldehyde is further 
oxidized to 3PBA (3-phenoxybenzoic acid. The alcohol and aldehyde moieties of 
pyrethroids are mainly metabolized by oxidation to the corresponding aldehydes and 
carboxylic acids by ADH and ALDH in mammalian species (23). The terminal phase 
of pyrethroid metabolism is the formation of glucuronide and glycine conjugates 
(24). These pathways appear similar between laboratory animals and humans. 
Common metabolites are found in the urine of both laboratory animals and humans 
(24, 25). 
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Fig. 2 metabolic pathways of cis- and trans- permethrins  
The 3-phenoxybenzoic acid (3-PBA) metabolite is common to 10 of the 18 
pyrethroids registered in the United States, including permethrin, cypermethrin, 
deltamethrin, esfenvalerate (26). Both type I and type II pyrethroids undergo ester 
hydrolysis which results in a cyclopropyl acid and either 3-phenoxybenzyl alcohol 
(type I) or a cyanohydrin (type II) (27). The aromatic alcohol is further oxidized to 3-
phenoxybenzoic acid (3PBA) while the cyanohydrin is able to spontaneously 
rearrange to the phenoxybenzaldehyde in aqueous solutions and then undergo 
hydroxylation to 3PBA. 3PBA is a nonspecific urinary metabolite, meaning that it is 
a breakdown product common to most of the pyrethroids with the exception of 
cyfluthrin. It is also the most frequently detected urinary metabolite in humans. 
3PBAcid has been detected in urine from the general population in the United States 
(0.32 μg/L), Germany (2.0 μg/L reference value), Italy (0.88 μg/L urban and 0.71 
μg/L rural) and Japan (0.29 μg/L;). Levels in occupationally exposed populations 
such as pest control workers tend to be higher (6.8 μg/g creatinine) (28). Since 3-PBA 
is a common metabolite for most pyrethroid pesticides, it has been used as a marker 
of pyrethroid exposure by the Centers for Disease Control and Prevention in the 
National Health and Nutrition Examination Survey study (29). The elimination half-
7 
life of about 8 h reported for 3-PBA among workers exposed to cypermethrin (30) 
suggests that 88% of the metabolite is excreted within the first 24 h following 
exposure. 
2.1.4 Excretion 
Permethrin and its metabolites are excreted primarily in the urine, but also in the 
feces (31,16). In rats given oral doses of permethrin, the excretion half-life was 
measured at 12.3 hours for plasma and from 9 to 23 hours for certain brain and 
nervous tissue, including the medulla oblongata (15). 
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2.2 Cardiotoxicity 
Cardiovascular disease (CVD) is the leading cause of death in the world. Although 
the largest risk factors of CVD are smoking, hypertension, diabetes, 
hypercholesterolemia, environmental pollutions contributing to cardiovascular 
defects, data from the National institute of Environmental Health Science (NIEHS) 
demonstrated a relationship between the levels of airborne particles, environmental 
agents such as dioxins and pesticides and risk of early death for heart disease. 
Pyrethroid insecticides are known to modify neuronal sodium channels, where 
cardiac myocytes are also rich and to interact with calcium ATP-ase (32). A work on 
rat myocytes shows that type I and type II pyrethroids prolong action potentials and 
extend the duration of sodium currents measured by voltage clamp (33). In isolated 
hearts, they augmented the contractile variability producing a cardiac arhythmogenic 
potential (33,34). Cardiovascular diseases such as coronary heart disease are 
associated with increased generation of reactive oxygen species (ROS) (35). 
Oxidative stress is dependent on the balance between oxygen free radical production 
and the anti-oxidant capacity of the cell; in its imbalance, oxidative stress may induce 
reversible or irreversible myocardial damage (36). ROS interact with intracellular 
signaling pathways involved in the control of vascular function, causing rapid 
damage to membrane lipids, proteins and DNA (37). Oxidative DNA base 
modifications have been demonstrated in hearts and isolated myocytes subjected to 
oxidant injury, including ischemia-reperfusion (38) and indicating that this cell type 
is susceptible to oxidant-induced DNA damage (39). A response by cells subjected to 
DNA damage is lesion repair rather than apoptosis or necrosis, which depends on the 
type and the concentration of toxin interacting with the cells. DNA repair utilizes 
enzymes that excise oxidized bases before DNA replication (40). Because cardiac 
myocytes are post-replicative, repair of DNA lesions is important to avoid 
deterioration of cardiac function that would eventually attend myocyte loss. The 
endonucleases activity increases in response to oxidative stress induced after 
permethrin exposure. SOD (superoxide dismutase) and Gpx (glutathione peroxidase) 
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enzymes play a key role in the protection against oxidative damage. In the heart of 
adult rats treated with permethrin (PERM) during early life, SOD activity was not 
modified, while a significant increase in Gpx activity and a consequent reduction in 
GSH levels were measured. The alteration in the enzymatic antioxidant response may 
be related to early life exposure to (PERM), where oxidative stress in the 
myocardium reflects a decrease in GSH content (41). Moreover is well known that 
ROS can initiate NF-kB-mediated transcriptional activation of inflammation genes 
(42).A wide range of cardiac diseases has been linked with inflammation and 
cytokine modulation (42). Cytokines have direct and indirect effects on myocardial 
function and these are time, concentration and subtype-specific (42). The relation 
between cytokine production and modulation of heart function is linked to the 
cytokine specific effect on exciting-contraction coupling, where TNF-α, IL-2 (43) 
and IL-6 modulate sarcoplasmic reticulum Ca
2+
 ATPase activity and IL-1β affects the 
inner calcium current (44). It is worth bearing in mind that oxidative stress conditions 
could also result from the increased pro-inflammatory cytokines levels, because they 
can induce xanthine oxidoreductase, NADPH oxidase and inducible nitric oxide 
synthase (iNOS) that consequently increase the level of free radicals leasing to 
deterioration of heart contractility (45). A report of FAO (46) provides that the level 
of permethrin residue in cardiac muscle was 0.1-0.2 % of dietary inclusion levels. 
Membrane fluidity of heart cells was reduced in the hydrophilic-hydrophobic region, 
while the hydrophobic interior results in a more fluid following PERM treatment 
(47). Moreover high concentration induces perturbation on heart plasma membrane. 
3PBALD can cross the membrane more easily than 3PBA. So, while 3PBALD exerts 
its effect mainly in the hydrophobic core, 3PBA can reduce the fluidity in the inner 
part of the membrane only at higher concentration and 3PBA, the less lipophilic 
metabolite, does not exert any damage in hydrophobic region, while its effect is 
present in the external part of bilayer. 3PBA can induce carbonyl group formation 
and it can be explained by the ease where by carboxyl group reacts with protein 
amino group. When metabolities are in the membrane, they can interact with lipids 
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forming crosslink and with proteins via amino group bond, modifying the 
macromolecule dynamics of the bilayer. This means that all the proteins inside the 
membrane, missing their mobility, will not guarantee the proper cell communication. 
The 3PBA is responsible for highest lipid peroxidation compared with the other two 
metabolites. This effect could be related with a major production of reactive oxygen 
species, as sub-products due to an increase in oxidative intracellular processes 
necessary to metabolize the compound. 
3PBA is the first metabolite of permethrin deactivation process and its complete 
metabolization requires more steps than the other two; this more articulated 
deactivation process likely leads to a highest ROS formation (48). Therefore METP 
has the capability to modify the sodium and calcium channels located at the bilayer 
level, a physicochemical modification of macromolecules inside the membrane could 
consequently influence also channels activity. Moreover, the oxidation of proteins 
could contribute to modify other membrane proteins changing the signal within heart 
cells. 
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3 Extraction methods: SPE Solid-phase extraction 
Solid-phase extraction (SPE) is a separation process used in order to separate 
compounds which are dissolved and suspended in a liquid mixture from other 
compounds according to their physical and chemical properties. Solid phase 
extraction is used by analytical laboratories to concentrate and purify samples for 
analysis and it can be also used to isolate analytes of interest from a wide variety of 
matrices, including urine, blood, water, soil, beverages and animals tissue (49). The 
affinity of solutes dissolved or suspended in a liquid (mobile phase) for a solid 
through which the sample is passed (stationary phase) is used in order to separate a 
mixture into desired and not desired components. The portion that passes through the 
stationary phase can contain desired analytes or undesired impurities. If the portion 
retained on the stationary phase includes the desired analytes they can then be 
removed from the stationary phase for collection in an additional step, in which the 
stationary phase is rinsed with an appropriate eluent. The stationary phase consists in 
a packed syringe-shaped cartridge, a 96 well plate or a 47- or 90-mm flat disk, each 
of which can be mounted on its specific type of extraction manifold. The manifold 
allows multiple samples to be processed by holding several SPE media in place and 
allowing for an equal number of samples to pass through them simultaneously. A 
typical cartridge SPE manifold can accommodate up to 24 cartridges. Most SPE 
manifolds are equipped with a vacuum port. Application of vacuum speeds up the 
extraction process by pulling the liquid sample through the stationary phase. After 
that the analytes are collected in sample tubes.. There is a variety of stationary phases 
which can separate analytes according to different chemical properties and which are 
usually based on silica that has been bonded to a specific functional group 
(hydrocarbon chains for reversed phase SPE, quaternary ammonium or amino groups 
for anion exchange and sulfonic acid or carboxyl groups for cation exchange) (49). 
Sodium chloride (NaCl) can be also added to the sample to improve the extraction 
efficiency (50). SPE cartridges should not be allowed to dry at any point during 
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conditioning and sample loading, in order to keep the sorbent ligands active and 
prevent air from trapping in the cartridges. It would be a good practice to transfer the 
upper layer (containing fewer solids) of the aqueous solution first and the lower layer 
(containing more solids) later because there can be a susceptibility to clogging when 
samples containing suspended solids are to be analyzed. Automation usually reduces 
or eliminates some variations due to manual extraction and it also shortens time 
required for extraction process.  SPE is normally used for samples that contain matter 
causing clogging and high back pressure and components that cause high 
background, misleading peaks or poor sensitivity. Clean-up, trace concentration or 
purification, sample matrix or solvent exchange are required for SPE process. SPE is 
often used because it switches sample matrix to a form compatible with 
chromatographic analyses and concentrates analytes for increased sensitivity. 
Moreover SPE can remove interferences and protect the analytical column from 
contaminants. 
3.1.1Normal Phase SPE procedure 
In a Normal Phase SPE procedure first of all the cartridge have to be equilibrated 
with a non-polar solvent or slightly polar, in order to wet the surface and penetrate 
the bonded phase. Then the silica surface is wet with water or buffer of a same 
concentration as the sample through the column The sample is then added to the 
cartridge. When the sample passes through the stationary phase, the analytes in the 
sample will interact and retain on the sorbent while the solvent, salts, and other 
impurities pass through the cartridge. After that buffer is used in order to wash the 
cartridge and remove impurities.. Then, the analyte is eluted with a non-polar solvent 
or a buffer of the appropriate pH. A stationary phase of polar functionally bonded 
silicas with short carbons chains frequently makes up the solid phase. This stationary 
phase will adsorb polar molecules which can be collected with a more polar solvent 
(49). 
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3.1.2Reversed phase SPE 
Analytes based on their polarity are separated with reversed phase SPE. The 
stationary phase of a reversed phase SPE cartridge is derivatized with hydrocarbon 
chains, which retain compounds of mid to low polarity due to the hydrophobic effect. 
The cartridge can be washed with a non-polar solvent, which breaks up the 
interaction of the analyte and the stationary (49). A stationary phase of silicon with 
carbon chains is commonly used. Only non-polar or very weakly polar compounds 
will adsorb to the surface (49). 
3.1.3 Ion exchange SPE 
Analytes based on electrostatic interactions are separated from the analyte of interest 
and the positively charged groups on the stationary phase using ion exchange 
sorbents. For ion exchange to occur, both the stationary phase and sample must be at 
a pH where both are charged. 
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4. Analytical methods, Gas Chromatography 
Gas Chromatography (GC or GLC) is a commonly used analytic technique in many 
research and industrial laboratories for quality control as well as identification and 
quantitation of compounds in a mixture. GC is also a frequently used technique in 
many environmental and forensic laboratories because it allows for the detection of 
very small quantities. A broad variety of samples can be analyzed as long as the 
compounds are sufficiently thermally stable and volatile. A mobile and a stationary 
phase are required for this technique. The mobile phase (carrier gas) is comprised of 
an inert gas i.e., helium, argon, or nitrogen. The stationary phase consists of a packed 
column where the packing or solid support itself acts as stationary phase, or is coated 
with the liquid stationary phase (a high boiling polymer). Most analytical gas 
chromatographs use capillary columns, where the stationary phase coats the walls of 
a small-diameter tube directly (i.e., 0.25 µm film in a 0.32 mm tube). The separation 
of compounds is based on the different strengths of interaction of the compounds 
with the stationary phase (“like-dissolves-like”-rule). The stronger the interaction is, 
the longer the compound interacts with the stationary phase and more time it takes to 
migrate through the column (=longer retention time). The factors which influence the 
separation of the components are: 
-Boiling point: The boiling point of a compound is often related to its polarity. The 
lower the boiling point is, the shorter is the retention time because the compound will 
spent more time in the gas phase. The temperature of the column does not have to be 
above the boiling point because every compound has a non-zero vapor pressure at 
any given temperature, even solids. 
-The polarity of components versus the polarity of stationary phase on column: If the 
polarity of the stationary phase and compound are similar, the retention time 
increases because the compound interacts stronger with the stationary phase. As a 
result, polar compounds have long retention times on polar stationary phases and 
15 
shorter retention times on non-polar columns using the same temperature.  
-Column temperature: An excessively high column temperature results in very short 
retention time but also in a very poor separation because all components mainly stay 
in the gas phase. If the compound does not interact with the stationary phase, the 
retention time will decrease. At the same time, the quality of the separation 
deteriorates, because the differences in retention times are not as pronounced 
anymore.  
-Carrier gas flow rate: A high flow rate reduces retention times, but a poor separation 
would be observed as well. Like above, the components have very little time to 
interact with the stationary phase and are just being pushed through the column. 
Column length: A longer column generally improves the separation. The trade-off is 
that the retention time increases proportionally to the column length and a significant 
peak broadening will be observed as well because of increased longitudinal diffusion 
inside the column.  Amount of material injected: Ideally, the peaks in the 
chromatogram display a symmetric shape. If too much of the sample is injected, the 
peaks show a significant tailing, which causes a poorer separation. Most detectors are 
relatively sensitive and do not need a lot of material in order to produce a detectable 
signal.  
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4.1 GC-ECD 
Electron capture detectors (ECD) are typically used in environmental testing for 
detecting PCB’s, organochlorine pesticides, herbicides and various halogenated 
hydrocarbons.  
ECD consists of a cavity that contains two electrodes and a radiation source that 
emits -radiation (i.e., 
63
Ni, 
3
H). The collision between electrons and the carrier gas 
(methane plus an inert gas) produces a plasma-containing electrons and positive ions. 
If a compound is present that contains electronegative atoms, those electrons will be 
“captured” to form negative ions and the rate of electron collection will decrease. The 
detector is extremely selective for compounds with atoms of high electron affinity 
(10
-14
 g/s), but has a relatively small linear range (~10
2
-10
3
). 
4.2 GC-MS 
Gas chromatography mass spectrometry (GC/MS) is an analytical method that 
combines the features of gas-liquid chromatography and mass spectrometry to 
identify different substances within a test sample. In order for a compound to be 
analysed by GC/MS it must be sufficiently volatile and thermally stable and some of 
them require a chemical modification (derivatization), prior to analysis, to eliminate 
undesirable adsorption effects that would otherwise affect the quality of the data 
obtained. The sample solution is injected into the GC inlet where it is vaporized and 
swept into a chromatographic column by the carrier gas (usually helium). The 
molecules are retained by the column and then elute from the column at different 
retention times. In that way mass spectrometer capture, ionize, accelerate, deflect and 
detect the ionized molecules separately. The latter part of the column passes through 
a heated transfer line and ends at the entrance to ion source where compounds eluting 
from the column are converted to ions. The next component is a mass analyser 
(filter), which separates the positively charged ions according to various mass related 
properties depending upon the analyser used. After the ions are separated they enter a 
17 
detector the output from which is amplified to boost the signal. The detector sends 
information to a computer that records all of the data produced, converts the electrical 
impulses into visual displays and hard copy displays. In addition, the computer also 
controls the operation of the mass spectrometer. 
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5. Experimental Part 
5.1 Reagents 
The reagents used were: hexane, acetonitrile (ACN), magnesium sulfate (MgSO4), 
PSA, sodium acetate (CH3COONa), C18, Chloridric acid (HCl) 1M and 12M, 
potassium hydroxide 10M (KOH), ethyl acetate (CH3COOCH2CH3), metanol 
(MeOH), ammonium hydroxide pH 10 (NH4OH), metanol 5% in ethyl acetate, 
1,1,1,3,3,3-Hexafluoro -2-propanol (HFIP),  N,N-Diisopropylcarbodiimid (DIC), 
potassium carbonate (K2CO3). 
5.2Solutions preparation 
12.09mg of permethrin have been weighted in a 5mL flask. With this amount of 
permethrin were prepared: 
o Permethrin solution 1 (1209mg/L) 
o Permethrin solution 2 (10mg/L) 
o Permethrin solution 3 (500μg/L) 
o Permethrin solution 4 (625 µg/L) 
o Permethrin solution 5 (125μg/L) 
Two series of standards for calibration curve were prepared: 
1.Concentrations: 0.3mg/L,0.4mg/L, 0.6mg/L, 0.8mg/L,0.9mg/L; 
2.Concentrations: 0.5mg/L,0.4mg/L,0.3mg/L,0.2mg/L,0.1mg/L,0.05mg/L,0.02mg/l; 
Buffer solution pH7: 
2.86mL of glacial acetic acid have been taken, put in a flask and diluted with H2O 
until 500mL (Solution A). 
19 
On the other hand 6.8gr of CH3COONa have been taken, put them in a flask and 
diluted with H2O until 500mL (Solution B). 
The buffer solution has been prepared with 89.25mL of solution A and 160.75mL of 
solution B. 
Moreover some solutions have been prepared with 3-PBA and with 2-PBA: 
 
 3-PBA solution 1 : 2000mg/L, 
 3-PBA solution 2: 10mg/L 
 3-PBA solution 3: 50µg/L 
 3-PBA solution 4: 5 µg/L 
 3-PBA solution 5: 2 µg/L 
 2-PBA solution 1: 2000 mg/L 
 2-PBA solution 2: 10mg/L 
 2-PBA solution 3: 50µg/L 
For 3PBA and 2PBA calibration curves were prepared: 
Concentrations 3PBA: 0.01µg/L, 0.05µg/L, 0.1µg/L, 0.3µg/L, 0.5µg/L, 1µg/L, 
1.5µ/L 
Concentration 2PBA; 20µg/L 
Ions selected for the identification of metabolites 3-PBA and 2-PBA are:  
135:169; 141; 195; 197.  
The most abundant ion for metabolite 3-PBA is 364  
The most abundant ion for metabolite 2-PBA is 195. 
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A NH4OH solution with a pH 10 was prepared through the dilution of pure NH4OH. 
5.3 Sampling 
8 Female rats were treated with permethrin from 6 to 21 days of life. Then 3 of them 
were sacrificed the day after (22 days of life) and the other 5 14 days after the 
treatment (35 days of life). Hearts and urine were collected (data of the collection 
29/10/2013) from these rats.  
The samples were at -20°C until analysis, which were made at room temperature. 
5.4 Sample preparation 
In order to carry out this study, samples (rat's heart) have been homogenized with a 
drill by a Torax equipment and preserved in approximately 5mL of ACN at -20°C. In 
order to determinate the concentration of 3-PBA, 2-PBA and Permethrin, several tests 
were performed. 
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For preliminary studies only the buffer solution was used: 
 
 
Fig. 3- Scheme of procedure for preliminaries tests 
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The Solid phase extraction (SPE) consisted in: 
Conditioning: 
 5mL of Ethyl acetate (AcOEt) 
 5mL of MeOH 
 5mL of H2O 
 5mL of HCl 
Add sample: 
 5mL of sample 
Cleaning: 
 5mL of HCl 
 5mL of NH4OH 
Drying 
Elution: 
 5mL of 
  5% MeOH in AcOEt 
Before injection in GC a derivatization was performed, the procedure is described in 
figure 4. 
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Fig.4- Scheme of derivatization procedure 
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Several hearts obtained from rats, not treated with permethrin, were used in order to 
standardize the method. The general procedure with hearts is described in figure 5. 
 
Fig. 5- Scheme of procedure to standardize the method 
During the tests several changes have been carried to the method, namely: 
 At first samples have been filtrated with filter paper in the beginning of test. 
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Then only the aqueous phase was filtrated in order to prevent a loss of 
Permethrin. 
 The minutes of ultrasound were increased from 10’ to 20’ to have a clear 
separation between the aqueous phase and the supernatant. 
 The procedure of derivatization has been modified; 150µL of n-hexane were 
added twice during liquid-liquid extraction instead of 250 µL of n-hexane, to 
improve the concentration of 3-PBA and 2-PBA. 
In order to verify the method, several tests were performed using samples from rats 
treated with Permethrin that are described in Figure 6: 
 
 
Fig.6-Scheme of procedure with samples from rats treated with permethrin 
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The permethrin, 3-PBA and 2-PBA -data from hearts from permethrin treated rats 
were obtained with the procedure described in figure 7. 
A control with buffer and enzyme but without sample was performed. Only results 
with higher values than the achieved by the control was processed.  
 
Fig.7-Scheme of procedure with samples from rats treated with permethrin  
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3-PBA values from urines were obtained with the procedure described in figure 8. 
 
Fig.8: Scheme of procedure with urines from rats treated with permethrin  
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5.5 Results and discussion 
  5.5.1 Chromatographic results 
 5.5.1.1 GC-ECD retention time, linearity, calibration curve Permethrin 
A solution containing permethrin was injected in GC-ECD and the retention time was 
recorded. Figure 9 shows the chromatogram obtained. 
 
Fig.9- Chromatogram retention time permethrin 
Five standards of permethrin were injected in GC-ECD. Figure 10 shows the 
achieved calibration curve for Permethrin. It was observed linearity between 0.3 to 
0.9 µg/L of permethrin in n-hexane. A R
2
 higher then 0.9842 was achieved. 
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Fig. 10- Calibration curve Permethrin 
  5.5.1.2 GC-MS retention time, linearity, calibration curve  
The retention time of 3-PBA was obtained by the injection in SIM mode of a 
derivatized solution. Figure 11 shows the chromatogram obtained. 
 
 
Fig.11-chromatogram retention times 3-PBA and 2-PBA 
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In figure 12 is shown the calibration curve for 3-PBA. It was observed linearity 
between 0.01 to 1.5 µg/L of 3-PBA. A R
2
 higher then 0.9864was achieved. 
 
 
Fig. 12- Calibration curve 3-PBA 
The achieved retention time of 2-PBA was 8.9 min as is shown in figure 11. The 
average area obtained in all chromatograms with 20 µg/L was 497601.2. 
 
5.5.2 Recoveries 
The recoveries were obtained using the quotient between the area obtained with the 
tested procedure and the area obtained with a standard. The 3-PBA and 2-PBA 
recoveries obtained with buffer solution was 78% and 58%, respectively. Identical 
procedure was performed with samples from rats not treated with permethrin in 
buffer solution. The recoveries of 3-PBA obtained with different tested procedures 
(ultrasounds 10’ and 20’) are shown in figure 13: 
y = 111977x + 17550 
R² = 0,9864 
0
20000
40000
60000
80000
100000
120000
140000
160000
180000
200000
0 0,5 1 1,5 2
A
re
a 
Concentration 
Calibration curve 3-PBA 
Valori Y
Lineare (Valori Y)
31 
 
Fig. 13- Recoveries of 3-PBA obtained in samples with different procedures 
The highest recovery is obtained with the procedure that uses 20 min in ultrasounds, 
achieving 70% of recovery.  
The recoveries of 2-PBA obtained with different procedures are shown in figure 14: 
 
Fig. 14-Recoveries of 2-PBA obtained with different procedures 
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Both procedures,10 minutes and 20 minutes in ultrasounds achieved recoveries of 2-
PBA near 100%. It was selected 20 minutes because 3-PBA reached better results. 
The amounts of Permethrin and  3-PBA in hearts from female rats treated with 
permethrin were obtained using the equations from the calibration curves. Figure 15 
shows the parallel between quantities  of Permethrin in hearts of female rats treated 
with permethrin and sacrificed the day after the treatment (22 days of life) and hearts 
of female rats treated with permethrin and sacrificed  14 days after the treatment (35 
days of life). 
 
 
Fig. 15: Concentrations of Permethrin in hearts 
Permethrin was found in hearts of rats sacrificed after 24h of the end of treatment 
with permethrin and even in hearts of rats sacrificed after 14 days. The concentration 
of Permethrin in rats sacrificed after 24 hours is a little bit lower than the 
concentration of permethrin in hearts of rats sacrificed after 14 days. 
Figure 16 shows the parallel between quantities  of 3-PBA in hearts of female rats 
treated with permethrin and sacrificed the day after the treatment (22 days of life) and 
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hearts of female rats treated with permethrin and sacrificed  14 days after the 
treatment (35 days of life). 
 
  
Fig.16- Concentrations of 3-PBA in hearts 
3-PBA was found both in hearts of rats sacrificed after 24 hours and after 14 days of 
the end of treatment with permethrin.  The concentration of  3-PBA in hearts of rats 
sacrificed after 24 hours is higher than that one in hearts of rats sacrificed after 14 
days (2.24 times greater). This results are in agreement with literature (30) where the 
excretion half time of permethrin’s metabolite is measured at 24 hours following 
exposure. 
This work demonstrated as other studies, that both Permethrin and its metabolite 3-
PBA get to the heart. Consequently it can be deduced that cardio-toxicity is due  both 
to direct and indirect effects of Permethrin. 
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The amounts of 3-PBA in urines of female rats treated with permethrin were 
calculated using the equations of calibration curves.                            
Figure 17 shows the quantities of 3-PBA in urines of rats sacrificed the days after and 
14 days after the treatment with permethrin. 
 
 
Fig. 17: Concentrations of 3-PBA in urines 
As it’s possible to see from figure 17, 3-PBA was found both in urines of rats 
sacrificed after 24 hours and after 14days of the end of treatment with permethrin.   
The concentration of  3-PBA in urines of rats sacrificed after 24hours is almost 50 
times greater than the concentration of 3-PBA in urines of rats sacrificed after 14 
days of the end of treatment.  These data are in agreement with results published by 
other authors (30). 
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6. Conclusions 
A concentration of  0.11µg/L of Permethrin was found  in hearts of rats sacrificed 
after 24 hours. A similar concentration (0,12 µg/L) has been found in hearts of rats 
sacrificed after 14 days of the end of treatment.  
The pyrethroid metabolite 3-PBA has been also found both in hearts of rats sacrificed 
after 22 days of life and after 35 days of life. The concentration of 3-PBA found in 
hearts of rats sacrificed after 24 hours resulted higher than the concentration of 3-
PBA in hearts of rats sacrificed after 14 days. In urines of rats sacrificed 24 hours 
after the end of treatment was found a concentration of  3-PBA almost 50 times 
greater than the concentration of 3-PBA in urines of rats sacrificed after 14 days.  
While the concentration of permethrin in hearts grows slightly day by day, the 
concentration of 3-PBA decreases. Moreover even the concentration of 3-PBA in 
urines decreases between rats sacrificed after 24 hours and rats sacrificed after 14 
days after the treatment with permethrin. That results are in agreement with the time 
of excretion of 3-PBA, which is within the first 24h following permethrin exposure.   
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Calculations Permethrin  solutions: 
 
C1*V1=C2*V2 
 Permethrin solution1= 12.090µg/10*10^-3 = 1209 mg/L 
 
 Permethrin solution 2 = 1209mg/L *V1= 10mg *5000µL 
V1= 41.36µL 
Then 41.36µL from the flask and have been taken and put in another 5 ml flask,after 
that  hexane has been added untill the flask’s line of demarcation (5ml). 
 Permethin solution 3= 10mg/L*V=0.5mg/L*1000µL 
Vm2= 50µL 
From the flask containing the mother solution 2, 50 µL have been taken and 
transferred then in microvial. Then hexane has been added until 1 ml. 
 Permethrin solution 4=  500µg/L*V=0.625 µg/L*5000 µL 
V= 6.25 µL 
6.25 µL from the flask and have been taken and put in another 5 ml flask,after that  
hexane has been added untill the flask’s line of demarcation (5ml). 
 Permethrin solution 5: 0.625 µg/L*V= 0.125 µg/L*5000 µL 
V=1000 µL 
1000 µL from the flask and have been taken and put in another 5 ml flask,after that  
hexane has been added untill the flask’s line of demarcation (5ml). 
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Permethrin calibration curve: 
 
 
 
 
 
Table 1: Permethrin area 
10mg*V= 0.3µg/L*1000µL V=30µL 
30µL have been taken from permethrin solution  of 10mg/L and hexane was added  
10mg*V= 0.4µg/L*1000µL V=40µL 
40µL have been taken from permethrin solution  of 10mg/L and hexane was added 
until 1mL. 
10mg*V= 0.6µg/L*1000µL V=60µL 
60µL have been taken from permethrin solution  of 10mg/L and hexane was added 
until 1mL. 
10mg*V= 0.8µg/L*1000µL V=80µL 
80µLhas been taken from permethrin solution  of 10mg/L and hexane was added 
until 1mL. 
10mg*V= 0.9µg/L*1000µL V=90µL 
Concentration Area 
0.3µg/L 404822 
0.4 µg/L 706464 
0.6 µg/L 938850 
0.8 µg/L 1454210 
0.9 µg/L 1689112 
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90µLhas been taken from permethrin solution  of 10mg/L and hexane was added 
until 1mL. 
Calculations 3-PBA solutions: 
In 5mL of ACN 10mg of 3-PBA were added. 
 3-PBA solution1 = 10000µg/ 5*10^-3L= 2000mg/L 
 3-PBA solution 2= 2000mg/L*V=10mg/L*10mL 
V=0.05mL 
0.05mL was taken from the 3-PBA solution of 2000mg/L. Then acetonitrile was 
added until 10mL. 
 3-PBA solution 3= 10mg/L*V=0.05mg/L*10mL 
V=0.05mL 
0.05mL was taken from the 3-PBA solution of 10mg/L. Then acetonitrile was added 
until 10mL. 
 3-PBA solution 4= 10mg/L*V=50µg/L*10mL 
V=0.05mL 
0.05mL was taken from the 3-PBA solution of 10mg/L. Then acetonitrile was added 
until 10mL. 
 3-PBA solution 5= 50µg/L*V=2µg/L*10mL 
V=0.4mL 
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0.4mL was taken from the 3-PBA solution of 50µg/L. Then acetonitrile was added 
until 10mL. 
In 5mL of ACN 10mg of 2-PBA were added. 
 2-PBA solution1 = 10000µg/ 5*10^-3L= 2000mg/L 
 2-PBA solution 2= 2000mg/L*V=10mg/L*10mL 
V=0.05mL 
0.05mL was taken from the 3-PBA solution of 2000mg/L. Then acetonitrile was 
added until 10mL. 
 2-PBA solution 3= 10000µg/L*V=50µg/L*10mL 
V=0.05mL 
0.05mL was taken from the 2-PBA solution of 10mg/L. Then acetonitrile was added 
until 10mL. 
 
For 3PBA and 2PBA calibration curves were prepared: 
Concentrations 3PBA: 0.01µg/L, 0.05µg/L, 0.1µg/L, 0.3µg/L, 0.5µg/L, 1µg/L, 
1.5µ/L 
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3-PBA calibration curve 
 
 
 
 
 
 
 
Table 2: 3-PBA area 
 
2µg/L*V= 0.01µg/L*5µL V=25µL 
2µg/L*V= 0.05µg/L*5µL V=125µL 
2µg/L*V= 0.1µg/L*5µL V=250µL 
2µg/L*V= 0.3µg/L*5µL V=750µL 
2µg/L*V= 0.5µg/L*5µL V=1.25mL 
2µg/L*V= 1µg/L*5µL V=2.5mL 
2µg/L*V= 1.5µg/L*5µL V=3.75mL 
 
 
Concentration 3-PBA Area 3-
PBA 
0.01 µg/L 13744 
0.05 µg/L 19729.67 
0.1 µg/L 22358.33 
0.3 µg/L 59872.5 
0.5 µg/L 85899 
1 µg/L 126342 
1.5 µg/L 182345.7 
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Calculation concentration of permethrin in hearts of rats sacrificated after 24h:  
 Area 
Sample 1 17525.13 
Sample 2 27390 
Sample 3 27245.45 
 
Table 3: Permethrin area in hearts of rats sacrificed after 24hours 
Equation calibration curve permethrin: y=2*10^6 – 195546 
Sample 1  
 (17525.13+195546)/ 2*10^6= 0.107µg/L 
Sample 2 
(27390+195546)/ 2*10^6= 0.112µg/L 
Sample 3 
(27245.45+195546)/ 2*10^6= 0.111µg/L 
 
Average samples: (0.107+0.112+0.111)/3= 0.110 µg/L 
 
Calculation concentration of permethrin in hearts of rats sacrificated after 14days 
 Area 
Sample 1 32633.4 
Sample 2 33668.8 
Sample 3 11623.1 
Sample 4 35224.6 
47 
Sample 5 56397.4 
 
Table 4: permethrin area in hearts of rats sacrificed after 14 days 
Sample 1  
 (32633.4+195546)/ 2*10^6= 0.114µg/L 
Sample 2 
(33668.8+195546)/ 2*10^6= 0.115µg/L 
Sample 3 
(11623.1+195546)/ 2*10^6= 0.104µg/L 
Sample 4 
(35224.6+195546)/ 2*10^6= 0.115µg/L 
Sample 5 
(56397.4+195546)/ 2*10^6= 0.126µg/L 
Average samples: (0.114+0.115+0.104+0.115+0.126)/5= 0.12µg/L 
Calculation concentration of 3-PBA in hearts of rats sacrificated after 24h: 
 Area 
Sample 1 436054.7 
Sample 2 236594 
Sample 3 645277.7 
Table 5: 3-PBA area in hearts of rats sacrificed after 24 hours 
Equation calibration curve 3-PBA : y=111977x + 17550 
 
Sample 1  
48 
(436054.7-17550)/111977= 3.59 µg/L 
Sample 2  
0 µg/L 
 
Sample 3 
(645277.7-17550)/111977= 5.61 µg/L 
Average samples : (3.59+5.61+0)/3= 3.07µg/L 
 
Calculation concentration of 3-PBA in hearts of rats sacrificated after 14days: 
 Area 
Sample 1 86913 
Sample 2 787280 
Sample 3 197933.3 
Sample 4 269918.5 
Sample 5 121842.3 
Table 6: 3-PBA area in hearts of rats sacrificed after 14 days 
Sample 1 
0µg/L 
Sample 2 
(787280-17550)/111977= 6.87 µg/L 
Sample 3 
0µg/L 
Sample 4 
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0µg/L 
Sample 5 
0µg/L 
Average samples : (0+6.87+0+0+0)/5= 1.37 µg/L 
 
Calculation of 3-PBA in urines of rats sacrificed after 24h: 
 Area 
Sample1 123369516 
Sample 2 181787279 
Sample 3 200621820 
Sample 4 358380967 
Sample 5 113235427 
Sample 6 162789863 
 
Table 7: 3-PBA area in urines of rats sacrificed after 24 hours 
Sample 1 
(123369516-17550)/111977= 1101.58 µg/L 
Sample 2 
(181787279-17550)/111977= 1623.28 µg/L 
Sample 3 
(200621820-17550)/111977= 1791.48 µg/L 
Sample 4 
(358380967-17550)/111977= 3200.33 µg/L 
50 
Sample 5 
(113235427-17550)/111977= 1011.08 µg/L 
Sample 6 
(162789863-17550)/111977= 1453.62 µg/L 
 
Average samples: (1101.58+1623.28+1791.48+3200.33+1011.08+1453.62)/6= 
1681.9µg 
Calculation of 3-PBA in urines of rats sacrificed after 14days: 
 Area  
Sample 1 18628900 
Sample 2 1968870 
Sample 3 1656695 
Sample 4 6669439 
Sample 5 3077413 
Table 8: 3-PBA area in urines of rats sacrificed after 14 days 
Sample 1 
(18628900-17550)/111977= 166.21 µg/L 
Sample 2 
0 µg/L 
Sample 3 
0 µg/L 
Sample 4 
0 µg/L 
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Sample 5 
0 µg/L 
Average samples: (166.21+0+0+0+0)/5= 33.42 µg/L 
 
 
